566C80

Known as: 566C80 hydroxynaphthoquinone, hydroxynaphthoquinone 566C80, hydroxynaphthoquinone, 566C80 
 

Topic mentions per year

Topic mentions per year

1989-2000
051019892000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Atovaquone (566C80), a hydroxynaphthoquinone, was investigated for activity against Plasmodium falciparum gametocytes (NF54… (More)
Is this relevant?
1993
1993
BACKGROUND Both trimethoprim-sulfamethoxazole and pentamidine are effective as treatments for Pneumocystis carinii pneumonia, but… (More)
Is this relevant?
1993
1993
Mutants of Toxoplasma gondii resistant to drugs that appear to affect the mitochondrial bc1 complex were isolated with the aid of… (More)
Is this relevant?
1993
1993
The causal prophylactic activity of the novel hydroxynaphthoquinone, 566C80, was assessed against the exo-erythrocytic (EE… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
The site of action of the antimalarial compound 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80… (More)
Is this relevant?
1992
1992
The in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii were evaluated… (More)
Is this relevant?
1991
1991
Compound 566C80, 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone, was studied for its in vitro and in vivo… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
1991
1991
566C80 is a novel hydroxynaphthoquinone with broad-spectrum anti-parasitic properties. In vitro the compound was more potent… (More)
Is this relevant?
1991
1991
Hydroxynaphthoquinone 566C80 was synthesised and initially developed as an antimalarial with potent activity against drug… (More)
Is this relevant?
1990
1990
The efficacy of a new class of drugs for Pneumocystis carinii pneumonitis was demonstrated. 566C80, a hydroxynaphthoquinone… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?